Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tripterygium glycosides versus acitretin for generalized pustular psoriasis
ChiCTR-TRC-12003542Phase 4Completed
- Sponsor
- Institute of Dermatology, Chinese Academy of Medical Sciences
- Start
- Jan 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tripterygium wilfordii polyglycosides and acitretin in generalized pustular psoriasis (GPP) (2 arms), sponsored by Institute of Dermatology, Chinese Academy of Medical Sciences. Primary endpoints: Time to no new pustules and drying of existing pustules and Pustule assessment score. Started Jan 2011; status: completed.
02
Drugs
tripterygium wilfordii polyglycosidesacitretin
03
Conditions
generalized pustular psoriasis (GPP)
Beyond the preview
Go deeper on ChiCTR-TRC-12003542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12003542.